Searching for prostate cancer screening in the UK can be confusing. Unlike some cancers, prostate cancer does not have a routine NHS screening invitation for everyone of a certain age. But that does not mean you must wait for symptoms before discussing your risk with a GP. Understanding what testing can and cannot tell you is the starting point.
Is prostate cancer screening available in the UK?
There is no population-wide prostate cancer screening programme. Most people are not automatically invited for regular PSA blood tests. However, men and anyone with a prostate can ask their GP about testing, even without symptoms. A GP can discuss possible benefits, limitations and individual risk.
The UK National Screening Committee updated its recommendation in March 2026. It supported targeted PSA testing every two years for men aged 45 to 61 with a disease-causing BRCA2 gene variant and a family history of breast, ovarian, pancreatic or prostate cancer. It did not recommend general screening or other targeted groups. England’s government says this targeted programme will begin rolling out in 2027. Access and arrangements may differ across the four UK nations, so check locally rather than assuming invitations have already started.
What does a PSA test measure?
PSA means prostate-specific antigen, a protein made by prostate tissue. A PSA test measures its concentration in a blood sample. It is often the starting point for a prostate check, but it cannot independently diagnose or rule out cancer.
A raised result may be associated with prostate cancer, but also with an enlarged prostate, inflammation or infection. Some people with cancer do not have a raised reading. Doctors interpret PSA alongside age, symptoms, medical history and sometimes earlier results. A single number rarely tells the whole story.
Who should discuss prostate cancer risk?
Prostate cancer risk increases with age. Black men have a higher risk, while a father or brother with prostate cancer can also be relevant. Inherited variants, particularly BRCA2, increase risk for some people. A family history of breast, ovarian or pancreatic cancer may therefore matter even when no relative has had prostate cancer.
These factors are reasons for an individual discussion, not a guarantee that repeated screening is beneficial. If BRCA2-related cancer runs in your family, ask your GP whether genetic counselling or assessment is appropriate. Learning about prostate cancer risk factors can also help you prepare questions.
When symptoms need a GP appointment
Early prostate cancer often causes no symptoms. Changes in urination are frequently due to non-cancerous problems, but they should be checked, particularly if new or worsening.
Tell your GP about difficulty starting urination, a weak stream, needing to urinate often or urgently, or waking frequently at night to use the toilet. Blood in urine or semen, unexplained weight loss and persistent back pain also need assessment. A previous normal PSA result should not be used to dismiss new symptoms.
Screening concerns people without symptoms; investigating symptoms is different. If something has changed, arrange a GP appointment rather than relying on a home risk questionnaire or a private blood test alone.
Preparing for a PSA blood test
The test is a straightforward blood sample, usually taken at a surgery or hospital. Preparation helps avoid misleading results. NHS advice is to avoid ejaculation, anal sex, cycling and strenuous exercise for 48 hours beforehand. You can normally eat and drink as usual.
If you have had a urine infection, you generally need to wait four to six weeks after it clears. Mention recent infections, prostate procedures and medication to your clinician, because these can affect interpretation.
Consider a 54-year-old who has booked a Monday test after a weekend cycling event. Instead of risking a temporarily affected result, he phones the surgery to ask whether to rearrange. That small precaution could avoid anxiety and an unnecessary repeat test.
What happens after a raised PSA result?
High PSA does not mean cancer has been diagnosed. A GP may repeat the test, check for infection or another explanation, and consider whether specialist assessment is necessary. Results typically take one to two weeks, although services vary.
Further prostate cancer tests can include an MRI scan to identify suspicious areas. If a specialist thinks it is necessary, a biopsy takes small tissue samples for examination. NICE recommends MRI as an initial investigation for suspected prostate cancer that appears confined to the prostate. A PSA number alone should not automatically lead to biopsy.
Not everyone needs every investigation. Symptoms, risk factors, MRI findings and personal preferences inform the plan. For additional context, understanding PSA blood test results and what happens during a prostate MRI are useful topics to explore.
Why is routine PSA screening debated?
Testing may detect a harmful cancer before symptoms begin, when treatment could be more effective. However, some prostate cancers grow so slowly that they would never cause problems during a person’s lifetime.
PSA testing can produce false alarms or miss some cancers. Further tests may cause anxiety or discomfort. Diagnosing a harmless, slow-growing cancer may also lead to treatment that was not needed, with potential consequences including urinary incontinence or erection problems. These concerns are called overdiagnosis and overtreatment.
Ask your GP not only whether a test is available, but what a normal or abnormal result might mean in your circumstances. Understanding the possible next steps is part of deciding whether testing is right for you.
Frequently asked questions
Can I request a PSA test without symptoms?
Yes. You can ask an NHS GP about PSA testing even without symptoms. They should discuss its benefits, limitations and suitability. Requesting a test is not the same as receiving a routine screening invitation.
At what age should men have a prostate check?
There is no universal age at which every man in the UK must start regular PSA tests. Age, family history, genetic risk and preferences matter. The new targeted BRCA2 recommendation applies to a specific group aged 45 to 61.
Does a normal PSA rule out prostate cancer?
No. A normal PSA reading cannot completely exclude cancer. Report persistent or changing symptoms to your GP even when a previous test was reassuring.
Is an MRI better than a PSA test?
They serve different purposes. PSA is a blood marker that may prompt investigation, while MRI examines the prostate for suspicious areas. A specialist decides which follow-up tests are appropriate.
Making an informed decision
Prostate cancer screening in the UK is moving towards targeted testing for a narrowly defined high-risk group, not routine checks for everyone. For most people, a conversation with their GP about symptoms, family history and the possible consequences of testing is the most useful next step. An informed choice is more valuable than a test taken without context.